Inventor · disambiguated record
Jeanmarie Guenot
Also filed as: GUENOT JEANMARIE · GUENOT JEANMARIE DEAN
17 granted patents·11 pending applications·240 citations·filing 2015–2024
94Inventor score
Files withHARPOON THERAPEUTICS INC16AMPHIVENA THERAPEUTICS INC7TOREADOR THERAPEUTICS INC2ANJI BRUNO LLC1MAVERICK THERAPEUTICS INC1
Top patents by PatentIndex Score
28 records- 0198US9708412B2Trispecific binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2016·Granted Jul 18, 2017·66 cites·12 claims
- 0296US10100106B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·27 cites·26 claims
- 0396US9920115B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·31 cites·12 claims
- 0495US10849973B2Prostate specific membrane antigen binding proteinHARPOON THERAPEUTICS INC·Filed 2017·Granted Dec 1, 2020·10 cites·8 claims
- 0595US10844134B2PSMA targeting trispecific proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2017·Granted Nov 24, 2020·12 cites·11 claims
- 0695US10066016B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2017·Granted Sep 4, 2018·34 cites·13 claims
- 0792US12128102B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Oct 29, 2024·1 cites·15 claims
- 0892US10954311B2Trispecific binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2017·Granted Mar 23, 2021·9 cites·21 claims
- 0992US10544221B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2017·Granted Jan 28, 2020·14 cites·17 claims
- 1092US9212225B1Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Dec 15, 2015·17 cites·14 claims
- 1190US9803029B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·11 cites·18 claims
- 1288US10626190B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 1385US2025197526A1Trispecific binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1484US10738118B2Methods of using bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2016·Granted Aug 11, 2020·3 cites·21 claims
- 1581US11623958B2Single chain variable fragment CD3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2020·Granted Apr 11, 2023·1 cites·24 claims
- 1680US11453716B2Single domain serum albumin binding proteinHARPOON THERAPEUTICS INC·Filed 2018·Granted Sep 27, 2022·1 cites·20 claims
- 1775US12084518B2Trispecific binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·0 cites·21 claims
- 1871US2024084009A1Single chain variable fragment cd3 binding proteinsHARPOON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1965US2021024654A1Bispecific CD33 and CD3 Binding ProteinsAMPHIVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2063US2025136690A1Multispecific binding protein compositions and uses thereofTOREADOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2161US2021100902A1Prostate specific membrane antigen binding proteinHARPOON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2260US11753469B2Methods of using bispecific CD33 and CD3 binding proteinsANJI BRUNO LLC·Filed 2020·Granted Sep 12, 2023·0 cites·22 claims
- 2359US2021095047A1PSMA Targeting Trispecific Proteins and Methods of UseHARPOON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2457US2025012806A1Methods and systems for super-resolution study of therapiesTOREADOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2544US2021324076A1Cd33×cd3 binding proteins for treating inflammatory conditions and diseasesAMPHIVENA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2643US2019225702A1Innate immune cell trispecific binding proteins and methods of useHARPOON THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2741US2018134789A1Inducible binding proteins and methods of useMAVERICK THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2840US2020262920A1Dosing regimen for cd3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeanmarie Guenot files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →